Treatment of PDGFRA expressing glioma cells with MEK inhibitor U0126 [44], [45] resulted in a transient decline of ERK phosphorylation, followed by up-regulated phosphorylation of ERK. This evidence concerns the gene MAP2K7 and central nervous system cancer.